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Summary 
Chronic hyperreactive onchodermatitis (sowda) is a severe form of onchocerciasis observed in 
a subset of individuals infected with the filarial  nematode Onchocerca volvuhs.  SDS-PAGE  and 
immunoblot analyses of Q  volvulus adult worm extracts were used to characterize the antigens 
of the marked antibody response of sowda patients. One 2.5-kD antigen was recognized by sera 
from all 35 (100%) sowda patients that were studied. In comparison, only 7 of 44 (16%) patients 
with generalized onchocerciasis and 11 of 21 (52%) of exposed individuals with no microfilariae 
in skin snips and no signs of disease showed reactivity to this antigen. Microftlaricidal treatment 
of sowda patients with improvement of the clinical status was associated with a decrease or 
disappearance of antibodies to the 2.5-kD antigen. Amino acid sequencing of the antigen indicated 
identity to human defensins 1-3 of neutrophils. Defensin was demonstrated by immunohistochemical 
staining in onchocercal nodules on the surface of adult filariae  and in the surrounding tissue. 
A  similar  staining  pattern  was  observed  for  other  proteins  present  in  neutrophils  such  as 
myeloperoxidase, elastase,  and  the L-1  protein complex (MRP  8/MRP  14),  indicating that 
neutrophils, macrophages, and their proteins predominate in the environment adjacent to the 
worms. These results demonstrate an association between the presence of autoantibodies to defensins 
and an infectious disease of known etiology. The association with a particular form of onchocerciasis, 
sowda, suggests a link between formation of autoantibodies to defensin and enhanced immune 
reactivity towards the parasite. 
H 
uman onchocerciasis affects approximately 20 million 
people in Africa, Central and South America, and Yemen 
(1). The major disease manifestations are dermal and ocular 
complications, including blindness. Onchocerciasis has been 
viewed as a disease in which the reaction of the host's im- 
mune system to the parasite, particularly to the microfilariae, 
is associated with pathology. According to clinical outcomes, 
people who have been exposed to Onchocerca volvulus fit into 
a spectrum that includes infected individuals with microfilariae 
and rather few clinical symptoms (generalized onchocerci- 
asis), individuals with few microfilariae but intense dermal 
pathology (sowda), and individuals with no microfilariae and 
no clinical symptoms (endemic controls) (2).  The general- 
ized form is immunologically characterized by a hyporespon- 
siveness to parasite antigens (3). In contrast, sowda is consid- 
ered hyperresponsive, and endemic controls are believed to 
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reflect resistance to onchocerciasis (2). Only a minority of 
infected individuals develop sowda, whereas the majority are 
presented with the generalized form. Sowda is characterized 
by a severe papular dermatitis, usually localized to one limb, 
with darkening of the skin, as well as pachydermia and local 
lymph node enlargement accompanied by extremely low 
numbers of microfilariae in the skin (4, 5). An immunolog- 
ical hyperreactivity is indicated by the fact that patients have 
significantly higher antibody titers, including IgE and antigen- 
specific IgG, compared to individuals with generalized on- 
chocerciasis (4, 6). Correspondingly, the regional lymph nodes 
show an extensive follicular hyperplasia (5). Skin lesions im- 
prove dramatically after long-term microfilaricidal treatment 
(7), indicating a relationship to the presence of microfilariae 
in the skin. It has been suggested that patients with sowda 
may possess effective  mechanisms to kill microfilariae, which 
lead to chronic inflammation and low numbers of parasites 
in the skin (4, 5). It is presently unclear which factors con- 
tribute to the development of sowda. Although differences 
regarding the strain of the parasites  (8) cannot be ruled out, 
differences  in  host reactivity appear  to  play a  major role. 
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association with HLA class II molecules has been found (9). 
Preferential reactivity of serum  pools from  sowda patients 
with O.  volvulus 9- and 72-kD antigens by antibodies of the 
IgG3 subclass has been reported (10). In this study, we have 
analyzed antigen recognition patterns  in  a larger group  of 
sowda patients that includes individuals who have been studied 
for up  to  5  yr  after microfilaricidal  treatment. 
Materials  and Methods 
Study Subjects.  After informed consent was obtained, residents 
of a hyperendemic area for onchocerciasis  in Liberia/West Africa 
were examined for the presence of onchocerciasis  as previously de- 
scribed (7, 9). Skin snips were taken bilaterally from the iliac crest 
and  examined microscopically for the  presence  of microfilariae 
(mf). 1 Sera were collected and stored at  -20~  for analysis. The 
individuals  included in the present study were grouped as follows: 
44 patients with generalized onchocerciasis  (31 male,  13 female, 
13-70 yr old, mf density, expressed  as geometric mean  =  31.12), 
35 patients with sowda (10 male, 25 female, 5-52 yr old, mf den- 
sity =  1.3), and 21 endemic controls, i.e., individuals  with no clin- 
ical signs of onchocerciasis  and no microfilariae in skin snips (11 
male,  10 female,  12-56 yr old, mf density=0). The patients with 
sowda received treatment with diethylcarbamazine (DEC) (7) or 
with ivermectin (150/~g/kg) when this became available. 15 sowda 
patients were studied during a 1-5-yr period after treatment. Five 
individuals with no previous exposure to O  volvuhs (nonendemic 
controls) and six German patients with lupus erythematosus were 
also  studied. 
0  volvuhs Antigen Preparation  (Ovag).  Adult O  volvulus worms 
were obtained by collagenase  digestion of surgically  removed on- 
chocercomata as previously described (11), homogenized in liquid 
nitrogen,  and antigens were extracted in 0.0625 M  Tris-C1, 2% 
SDS,  5  mM  EDTA,  2  mM  PMSF,  and  100 ~g/ml  tosyllysine- 
choloromethyl ketone. After centrifugation at 20,000 g for 90 min, 
the supernatant was stored at  -70~  Protein content was mea- 
sured using  the Bio-Rad protein assay kit (Bio-Rad,  Miinchen, 
Germany). 
1 Abbreviations  used in thispaper:  ms  microfilariae;  Ovag, Onchocerca  volvulus 
antigen preparation. 
SDS-PAGE and Immunoblotting.  Ovag was separated by SDS- 
PAGE using 5-15% and 12-17% gradient gels (12) and 12.5% Tri- 
cine gels (13). Gels were transferred to nitrocellulose membranes 
(Schleicher und Schuell, Dassd, Germany), and nitrocellulose strips 
were incubated at 4~  overnight with human sera diluted 1:50 
in PBS with 2.5% dry milk or with a mouse mAb to human defensin 
(Bachem, Heidelberg, Germany) diluted 1:20 in PBS/2.5% milk. 
After washing, strips were incubated with protein G-HRP (Bio- 
Rad) or with a goat anti-mouse IgG-HRP (Calbiochem, Bad Soden, 
Germany) for 2 h at room temperature and developed with 4-chloro- 
naphthol/HzO~. 
Partial  Amino Acid Sequence Analysis.  For protein sequence anal- 
ysis, Ovag separated by Tricine-SDS-PAGE was blotted onto a poly- 
vinylidene difluoride membrane (Applied  Biosystems,  Inc., Foster 
City, CA). After Coomassie blue staining, the antigen-containing 
band was excised and analyzed in a gas phase automated sequencer 
(model 473A;  Applied Biosystems). 
Immunohistochemical Techniques.  Onchocercal nodules and skin 
biopsies surgically removed from Liberian patients with sowda or 
generalized onchocerciasis were fixed in 4% buffered formaldehyde 
or ethanol. 3-6-/~m paraffin sections were incubated with one of 
the following: mouse monoclonal antibodies to purified human 
defensin (diluted 1:2,000-1:6,000;  Bachem), to the I.-1 protein com- 
plex (MKP 8 and 14) (MAC387, diluted 1:50; Dako, Hamburg, 
Germany), rabbit antisera to myeloperoxidase, or neutrophil elastase 
(both from Dako, diluted 1:5,000 and 1:150, respectively).  Detec- 
tion of binding was performed using either rabbit anti-mouse or 
mouse anti-rabbit immunoglobulins followed by incubation with 
an alkaline phosphatase-antialkaline phosphatase (APAAP)  com- 
plex according to the recommendations  of the manufacturer (Dako). 
StatisticalAnalysis.  The chi-square test with continuity correc- 
tion was  used for comparison between groups. 
Results 
Recognition of  a 2.5-kD Antigen by Sowda Sera.  SDS-PAGE 
and immunoblots of Ovag showed preferential recognition 
of low molecular weight  antigens  by sera from  sowda pa- 
tients compared to sera from patients with generalized on- 
chocerciasis and endemic controls (data not shown).  Subse- 
quent  use of 12.5%  Tricine gels  showed recognition of an 
'~2.5 kD band by sera from sowda patients (Fig.  1 A). This 
antigen was recognized by 35 of 35 (100%) sowda patients 
Figure 1.  Serum  reactivity to the 2.5-kDa band is 
prominent in sowda patients. Tricine  gel and immuno- 
blot of Ovag probed with individual sera from patients 
with sowda (A), endemic  controls  (B), nonendemic  con- 
trol (C), and patients with generalized onchocerciasis 
(/9). All sera  in A and two sera  in B react  with the 2.5-kD 
band (arrow). 
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ciasis, and by 11 of 21 (52%) of endemic controls. The differ- 
ence was highly significant for the sowda group compared 
to the other  two groups(P  =  7.6  x  10 -11 andP  =  6.6 
X  10 -6,  respectively),  as well as for the endemic control 
versus  the  generalized  onchocerciasis  groups  (P  =  2  x 
10-3). No reactivity with serum from nonendemic controls 
(Fig.  1 C) or patients with lupus erythematosus (not shown) 
was seen. 
Differences in the intensity of the reaction to the 2.5-kD 
were observed. Thus, sera from sowda patients always showed 
strong reactivity (graded 2-3), whereas reactivity of sera from 
patients with generalized onchocerciasis or endemic controls 
was more variable (graded 1-3). Titration experiments per- 
formed on a subgroup of sera indicated that  reactivity did 
not change at a higher serum dilution  (1:100).  Conversely, 
a lack of reactivity persisted at lower serum dilutions (1:20). 
Reactivity to the 2.5-kD band correlated with the clinical 
status of patients with sowda. Of nine sowda patients treated 
repeatedly with DEC over a period of 1-5 yr, improvement 
of the clinical  condition correlated with a gradual decrease 
of antibody reactivity to the 2.5-kD band.  In  all patients, 
this  reactivity  disappeared  upon  remission  of the  sowda 
manifestations.  In these patients,  the skin had regained al- 
most normal appearance and no microfilariae were detected 
in skin snips.  A representative case is shown in Fig.  2.  Six 
sowda patients treated with a single oral dose of ivermectin 
showed no change in reactivity to the 2.5-kD antigen  1 yr 
after treatment,  which correlated with the lack of improve- 
ment  in the clinical  status. 
Identification of the 2.5-kD Band as Human Defensin.  NH2- 
terminal amino acid sequencing of the 2.5-kD band material 
over 22 positions  allowed identification  of 18  amino  acid 
residues (Fig.  3 A).  Assuming that  the four not identified 
residues represent cysteine residues,  then the entire 22 res- 
idue sequence is identical to the first 22 residues of human 
defensin HNP1 (14). HNP1 contains 30 amino acid residues 
and has a 3.45-kD molecular mass.  Approximately 30% of 
the  2.5-kD  material  lacked the  NH2-terminal  alanine  and 
might  therefore constitute HNP2 (14).  The antigenic rela- 
tionship of the 2.5-kD peptide to human defensin was indi- 
cated by its reactivity with  a mouse monoclonal antibody 
to human  defensin (Fig.  3 B, lane 2).  The additional  two 
bands reactive with the antibody may represent  multimers 
of defensin or prodefensin. 
Localization of Defensin in Onchocercal Nodules.  In studied 
sections of two patients with sowda and four with general- 
ized onchocerciasis,  immunohistochemical analysis of oncho- 
cercal nodules showed an inflammatory cell infiltrate composed 
of mainly neutrophils containing defensin and macrophages 
surrounding  adult  worms.  Neutrophils  were concentrated 
around the female worms. Intense staining for defensin was 
observed on the worm surface and in the surrounding tissue 
(Fig. 4 A), suggesting extracellular release of defensin by ac- 
tivated neutrophils.  Cellular infiltrates were associated with 
damage of the surrounding connective tissue (Fig. 4 A). Ad- 
jacent to larger  groups  of neutrophils,  many macrophages 
were lightly stained for defensin and often phagocytized neu- 
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trophils were observed in macrophages or multinuclear giant 
cells. Morphologically altered dead microfilariae with attached 
neutrophils  and staining for defensin extending to the sur- 
rounding  tissue also suggested that  neutrophils  were acti- 
vated by the worm to adhere and/or to release defensin (Fig. 
4 B).  Intact microfilariae without  any cellular infiltrate  or 
defensin were also observed (Fig.  4 C). The surface of adult 
worms showed a layer of intense staining for defensin with 
attached neutrophils  (Fig.  4 D).  This layer  appeared to be 
shed from the surface (Fig.  4 E).  No direct staining of in- 
ternal  structures of adult worms or morphologically intact 
microfilariae was detected. Staining of respective sections with 
antibodies to the neutrophil proteins myeloperoxidase,  elastase, 
and the L-1 protein complex resulted in similar staining pat- 
terns, all confirming the presence of neutrophils and macro- 
phages around the adult worms (not shown). The staining 
pattern most similar to that observed with antibody to defensin 
was observed with antiserum to myeloperoxidase, including 
the release and deposition of the protein on the worm sur- 
face and on microfilariae when surrounded by neutrophils. 
Staining with  anti-L-1  protein complex gave a similar re- 
sult. Staining with elastase was confined to the neutrophils, 
the release  of the protein was not observed and fewer cells 
were stained than  with  defensin. 
Discussion 
The results of this study demonstrates that the sowda form 
of onchocerciasis is associated with the occurrence of serum 
antibodies to a 2.5-kD antigen present in extracts of O. vol- 
vulus adult  worms. 
The amino  acid sequence suggested identity of this an- 
tigen with human defensins, a group of peptides with po- 
tent antimicrobial, cytotoxic, chemotactic, and corticostatic 
properties present in the azurophil granules of neutrophils 
(15). Autoantibodies to neutrophil cytoplasmic constituents 
(ANCA) have been known to occur in autoimmune diseases 
(16). Antigens identified so far are some of the enzymes of 
the azurophil granules,  such as myeloperoxidase, elastase, and 
proteinase 3. The most specific disease association is found 
between antibodies to proteinase 3 and Wegener's granuloma- 
tosis (17). Disease activity correlates with the presence of these 
antibodies,  suggesting a functional role of these antibodies 
in the disease process (16).  Here we found a correlation be- 
tween presence of autoantibodies to defensin and active dis- 
ease. Sowda shows certain parallels  to Wegener's granuloma- 
tosis, in that vasculitis, granulomas in the skin, and eosinophilia 
occur in both diseases. The differential diagnosis of tropical 
pulmonary eosinophilia,  which represents the sowda analogue 
in lymphatic filariasis, has to consider Wegener's granuloma- 
tosis (18). 
The presence of other neutrophil proteins in the vicinity 
of the worms and on the worm surface further  suggest an 
important role for neutrophils in the in vivo reaction to this 
nematode,  which needs to be characterized.  Differences in 
abundance and distribution of the individual proteins appear 
to exist. It will be of major interest to examine whether au- 
toantibody formation also occurs to these proteins in onchocer- Figure 2.  Serum reactivity to 
the 2.5-kD band correlates to dis- 
ease activity in sow&. (A) Immu- 
noblot of Ovag probed with serum 
from a sowda patient before (lane 
1) and at various times after long- 
term  microfilaricidal  treatment 
(lanes  2-6). Reactivity to the 2.5- 
kD band is seen before and 3 mo 
(lane 2), 24 mo (lane 3), 26 mo 
(lane 4) after treatment, and it is 
virtually  absent at 36 mo (lane 5) 
and 41 mo (lane  6) after treatment. 
The same patient before (/3) and 
36 mo after (C)  microfilaricidal 
treatment. The papular dermatitis 
and darkening of the skin, typical 
for sowda, disappeared  36 mo after 
treatment. 
Figure 4.  Distribution of defensin in onchocercal nodules. (A) Neutrophils and large amounts of defensin (red) concentrated around an adult female 
with deposition  of defensin on the worm surface. Sowda (x 243). (B) Damaged  dead microfilaria in onchocercoma tissue with attached neutrophils 
and extracellular defensin in the surrounding area (arrow). (C) Another intact microfilaria without cellular infiltrate or defensin (arrowhead). Sowda 
(x618). (D) Crust-like structure on surface of adult female (arrowhead)  with attached neutrophils and positively staining  material for defensin. Generalized 
(x618).  (E) Crust strongly stained by defensin antibody (arrow) in the proximity of an adult male, which is covered by a thin layer positively staining 
for defensin (arrowhead). Generalized (x618). A 
B 
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Figure  3.  Identity  of 2.5-kD band 
with human defensins. (.4) NH2-ter- 
minal protein sequence  of antigen in 
0  volvulus  extract  compared  to human 
defensin 1 (HNP1) (14). The single 
letter amino add  code is  shown, 
whereby  X means not identified. (B) 
Immunoblot of Ovag  probed  with an 
individual sowda  serum (lane 1) and 
mouse mAb to human defensin (lane 
2).  Arrow indicates position  of 
defensin. 
ciasis patients and exposed individuals.  In fact, ANCA staining 
has been recently observed in some onchocerciasis patients 
and local controls (19), yet no relationship  to clinical parameters 
was observed. Together with our findings,  this observation 
indicates the presence of an autoimmune response in onchocer- 
ciasis  that  may play an  important  role in the development 
of pathology.  The  autoimmune  response in this infectious 
disease is changed by treatment with the corresponding an- 
tiparasitic agent,  resulting in a decrease or disappearance of 
both autoantibodies and clinical manifestations. Since the eti- 
ology of most autoimmune diseases is unknown, these results 
may support the presumption of a link to infectious agents. 
The present results indicate a difference in incidence of au- 
toantibodies  to defensin between the  study groups.  How- 
ever, quantitative differences may be present among persons 
showing antibody reactivity to defensin, as suggested by the 
different intensities of the Western blot reaction of individual 
sera,  particularly during  the follow up.  Further  studies are 
needed to examine whether quantitative differences are related 
to  clinical  findings. 
A  major  question is why autoantibodies  to  defensin are 
produced preferentially by sowda patients. This does not ap- 
pear to result from the overall high antibody titers to (9, vol- 
vulus antigens observed in these patients since autoantibodies 
were also frequent  in endemic controls with low antibody 
titers to O. volvulus antigens (6, 20). A possible explanation 
for the autoantibody production would be that the antibodies 
are actually directed to parasite defensin or to other cross- 
reactive parasite antigens. However, our results strongly sug- 
gest that the defensin in the O  volvulus extract is of human 
origin and is deposited on the worm surface when neutro- 
phils become activated and degranulate in the proximity of 
the parasite.  Human neutrophils  are potent effector ceils in 
killing both microfilariae and infective larvae of O  volvulus 
(21, 22). Degranulation  with deposition of defensin on the 
worm  surface may trigger  mechanisms  of inactivation  of 
defensin, such as binding of ot2-macroglobulin and internali- 
zation of defensin by macrophages (15).  This suggests that 
defensin on the worm surface may be available for antigenic 
presentation  to T  cells. 
Production of autoantibodies is viewed as a T  cell-regu- 
lated phenomenon. Self-reactive B cells thus need T cell help. 
This help could be provided by two different mechanisms. 
One would require that defensin-reactive T cells are activated 
because of a failure of peripheral control mechanisms of self 
tolerance, such as clonal anergy (23). Alternatively,  autoreactive 
T  cells or B cells could directly be activated by parasite an- 
tigens  crossreactive with  human  defensin.  Crossreactivity 
cannot be ruled out at present, particularly as O  volvulus an- 
tigens that are cross-reactive with other human proteins have 
been detected (24-26). The second mechanism of T cell help 
would involve activation of T  cells reactive with conjugates 
between human defensin and onchocercal antigens. The ob- 
served parasite  surface material  that  stained  positively for 
defensin suggests formation of macromolecular complexes. 
This  possibility  would  be  consistent  with  the  view  that 
defensins as small peptides may not be able to induce an im- 
mune response by themsdves, but that  they need a carrier 
molecule,  in this case parasite molecules. 
Both these mechanisms  of T  cell help  to autoreactive B 
cells  require  a break in  T  cell tolerance.  Whereas  the first 
possibility would require a break in sdf-tolerance, the second 
possibility requires  a break in tolerance to onchocercal an- 
tigens.  The latter is applicable to patients with  generalized 
onchocerciasis who are tolerant to parasite antigens, reflected 
by lack of T  cell proliferation  and IL-2 production  (3).  As 
in classical tolerance, this state is reversible by addition of ex- 
ogenous IL-2 (3). Tolerance appears to be related to the pres- 
ence of microfilariae since microfilaricidal  treatment  of pa- 
tients can restore the cell-mediated immune response (3, 27, 
28). These findings  are consistent with the fact that  main- 
tenance of tolerance depends on the continued  presence of 
the toleragen  (29), in this case microfilariae.  In contrast  to 
patients with generalized onchocerciasis, persons with sowda 
or with no signs of onchocerciasis (endemic controls) show 
a different immune reactivity to the parasite. T cell reactivity 
to onchocercal antigens is marked in endemic controls (20), 
while a heightened T call reactivity in sowda patients is indi- 
cated by the granuloma  formation in the skin (5), which is 
considered  to reflect hypersensitivity. 
The  concept of tolerance to  explain  parasite-related  un- 
responsiveness has first been put forward for lymphatic filari- 
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antigens in utero (31). Our results indicate that under condi- 
tions of established tolerance to parasite antigens, as in gener- 
alized onchoceriasis,  no reactivity to defensins is seen. When 
tolerance to parasite  antigens is compromised (as in sowda) 
or is not established (as in endemic controls), production of 
defensin antibodies occurs. Thus, the observed strong associ- 
ation of autoantibodies to defensin with sowda and not with 
generalized onchocerciasis  is highly suggestive of a link be- 
tween autoantibody formation and enhanced immune reac- 
tivity to the parasite. 
The exact mechanisms underlying this relationship need 
further study. To date, the concept of molecular mimicry has 
been put forward to explain a possible relationship between 
autoimmune diseases and infectious agents (32).  Based on 
the present findings, we would like to propose that host an- 
tigens may become immunogenic by conjugation with para- 
sitic molecules. According to this model, autoantibody re- 
sponses would be under the control of parasite-specific T cells 
that are reactive with epitopes unrelated to the host antigen. 
This concept is supported by recent findings in studies of 
experimental autoimmune disease, where it was shown that 
autoantibody need not mirror the immunogen that initiated 
the immune response  (33).  Furthermore, this would be in 
accordance with the observation that in several autoimmune 
diseases, T cells reactive with the autoantigen are either not 
detectable or their presence is observed in normal individuals 
as well. 
The role of autoantibodies to defensin in onchocerciasis 
has to be determined. Such antibodies may be involved in 
cytotoxicity towards the parasite,  particularly microfilariae. 
Deposition of human IgG on O.  volvulus microfilariae  has 
been observed both in vitro (21) and in vivo in certain condi- 
tions, the latter in lymph nodes of patients with onchocerci- 
asis after treatment with ivermectin (Knab, J., K. Darge, and 
D. W.  B/~ttner,  manuscript in preparation). 
In view of the extremely close adaptation of O. volvulus 
to its human host, it is of considerable  interest to examine 
the mechanisms by which O.  volvulus down-regulates cell- 
mediated immunity, as well as the factors  that allow auto- 
antibody formation in this infectious disease. The study of 
human onchocerciasis  may cast light on the relationship be- 
tween autoimmunity and infection with a defined parasitic 
agent. 
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